Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00428233 · ClinicalTrials.gov registry record · Phase 1
Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation
A Phase 1 study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 65
- Enrollment target
NCT00428233 is a Phase 1 study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 65 participants.
The verdict
NCT00428233, a Phase 1 study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 65 participants
- Enrollment target
Study Summary
The purpose of this research study is to collect, freeze and store leukemia cells from the blood or bone marrow of patients that have advanced chronic lymphocytic leukemia (CLL) that is not in clinical remission. This study is a companion study to DF/HCC clinical trial 06-196 in which the participants' own CLL cells may form part of a vaccine treatment for their leukemia.
Interventions
- PROCEDURE Leukemia cell harvest
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2006-11 |
| Est. Completion | 2014-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00428233
The ClinicalTrials.gov registry entry for NCT00428233 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Leukemia cell harvest is the first listed.
NCT00428233 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00428233 about?
NCT00428233 is a clinical study titled "Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation". The purpose of this research study is to collect, freeze and store leukemia cells from the blood or bone marrow of patients that have advanced chronic lymphocytic leukemia (CLL) that is not in clinical remission. This study is a companion study to DF/HCC clinical trial 06-196 in which the participan...
What is the current status of trial NCT00428233?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 65 participants. The study started on 2006-11. Estimated completion is 2014-06.
What interventions are being tested in trial NCT00428233?
The interventions under investigation include: Leukemia cell harvest (PROCEDURE).
Who is sponsoring clinical trial NCT00428233?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.